Evidence map›Paper›PMID 33525590›Full record

ReviewInternational journal of molecular sciences2021

Role of NLRs in the Regulation of Type I Interferon Signaling, Host Defense and Tolerance to Inflammation.

Ioannis Kienes, Tanja Weidl, Nora Mirza, Mathias Chamaillard, Thomas A Kufer

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Infection and immunity · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Understanding the impact ofFrontiers in molecular biosciences · 2024
    Review
  16. Review
  17. Immunomodulatory Role of Interferons in Viral and Bacterial Infections.International journal of molecular sciences · 2023
    Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Ioannis KienesDepartment of Immunology, Institute for Nutritional Medicine, University of Hohenheim, 70599 Stuttgart, Germany.
Tanja WeidlDepartment of Immunology, Institute for Nutritional Medicine, University of Hohenheim, 70599 Stuttgart, Germany.
Nora MirzaDepartment of Immunology, Institute for Nutritional Medicine, University of Hohenheim, 70599 Stuttgart, Germany.
Mathias ChamaillardUniversity of Lille, Inserm, U1003, F-59000 Lille, France.ORCID 0000-0002-0243-9717
Thomas A KuferDepartment of Immunology, Institute for Nutritional Medicine, University of Hohenheim, 70599 Stuttgart, Germany.ORCID 0000-0003-4563-0412
University of Hohenheim · DEInserm · FR

Funding

Landesgraduiertenförderung of Baden-Württemberg IK
6 · The paper itself

Abstract

Type I interferon signaling contributes to the development of innate and adaptive immune responses to either viruses, fungi, or bacteria. However, amplitude and timing of the interferon response is of utmost importance for preventing an underwhelming outcome, or tissue damage. While several pathogens evolved strategies for disturbing the quality of interferon signaling, there is growing evidence that this pathway can be regulated by several members of the Nod-like receptor (NLR) family, although the precise mechanism for most of these remains elusive. NLRs consist of a family of about 20 proteins in mammals, which are capable of sensing microbial products as well as endogenous signals related to tissue injury. Here we provide an overview of our current understanding of the function of those NLRs in type I interferon responses with a focus on viral infections. We discuss how NLR-mediated type I interferon regulation can influence the development of auto-immunity and the immune response to infection.

Indexed as

Adaptive ImmunityAnimalsHumansImmunity, InnateInterferon Type INLR ProteinsSignal TransductionVirus DiseasesInterferon Type INLR Proteinsantiviralimmune regulationinnate immunityInterferonsNOD-like receptorssignalingtype I interferon

Identifiers

PMID33525590
PMCPMC7865845
OpenAlexW3123360715

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.